Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer.

In patients with CRT, however, CD133-positive cases tended to have shorter OS, although the difference did not reach statistical significance (Fig. 2 b).

also in 111,027 other papers